Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Age-related macular degeneration

J G O'Shea1

  • 1Department of Ophthalmology, University of Birmingham, UK.

Postgraduate Medical Journal
|July 31, 1998
PubMed
Summary

Age-related macular degeneration is a leading cause of blindness in the UK, affecting 18.5% of those 85 and older. This review covers its prevalence, risk factors, and current treatments for medical professionals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A history of the St John Ophthalmic Hospital, Jerusalem.

Proceedings of the Royal College of Physicians of Edinburgh·2001
Same author

A survey of vernal keratoconjunctivitis and other eosinophil-mediated external eye diseases amongst Palestinians.

Ophthalmic epidemiology·2000
Same author

The St John Ophthalmic Hospital: a medical ambassador in Jerusalem.

Eye (London, England)·1999
Same author

Glaucoma: diagnosis and management.

Postgraduate medical journal·1999
Same author

Excimer laser ophthalmic surgery: evaluation of a new technology.

Postgraduate medical journal·1999
Same author

Diabetic retinopathy.

Postgraduate medical journal·1998

Area of Science:

  • Ophthalmology
  • Geriatrics
  • Public Health

Background:

  • Macular degeneration accounts for 95% of blindness and partial sightedness registrations in the UK.
  • Prevalence increases significantly with age, reaching 18.5% in individuals 85 years or older.
  • A notable female predominance and a higher incidence of the exudative form are observed.

Purpose of the Study:

  • To inform the UK medical community about the prevalence and clinical features of age-related macular degeneration (AMD).
  • To review risk factors, patient-experienced disabilities, and current therapeutic strategies for AMD.

Main Methods:

  • This is a review article.
  • Information was gathered from existing literature on AMD prevalence, risk factors, clinical manifestations, and treatments.

Main Results:

  • AMD prevalence is negligible before age 55, rising to 18.5% by age 85+.
  • The condition shows a female preponderance and the exudative form is more common.
  • Most patients receive supportive care; a minority may benefit from laser photocoagulation.

Conclusions:

  • AMD is a significant public health concern in the UK, particularly among the elderly.
  • Awareness of AMD's epidemiology and clinical spectrum is crucial for healthcare providers.
  • While supportive care is standard, specific interventions like laser photocoagulation offer benefits to a subset of patients.

Related Experiment Videos